Search Results
Apixaban reduced thromboembolism risk in cancer patients
Benefits of apixaban among venous thromboembolism patients with active cancer
Reducing the Risk of Thromboembolism in Cancer
ASH12: Extending Apixaban Cut Risk of Venous Thromboembolism
Alok Khorana: Rivaroxaban Prevents Cancer-Associated VTE
Alok Khorana, MD: Prophylactic Treatment With Rivaroxaban Reduces Cancer Patients' VTE Risk
Bleeding, Gastrointestinal Cancer, & Apixaban, Rivaroxaban, or Enoxaparin for Acute VTE
"Apixaban for Cancer Patients: Reducing Clots but Increasing Bleeding"
Oral Anticoagulants in Cancer Patients: Mixed-Results and a Lesson about Trial Enrichment
CASSINI: can we prevent thrombosis in cancer patients who are at risk?
Clot Chronicles: Revisiting the Caravaggio Trial - Key Findings for Patients with Cancer and VTE
APIXABAN TO PREVENT VENOUS THROMBOEMBOLISM IN PATIENTS WITH CANCER
